insitro Stock
HealthTechInsitro is a pioneering drug discovery and development company that leverages machine learning and high-throughput biology to generate vast data sets. These data sets are designed to address the pressing challenges in pharmaceutical R&D. Insitro's unique approach enables the creation of predictive models, which are utilized to expedite the selection of drug targets, design and development of potent therapeutics, and to guide clinical strategy, thereby revolutionizing the way drugs are discovered and delivered to patients.
BlackRock, SoftBank Investment Advisers, HOF Capital, TLI Bedrock, Bezos Expeditions, Foresite Capital Management, GV, Alexandria Venture Investments, T. Rowe Price, Two Sigma Ventures, A&E Investments, HBM Genomics, Mubadala Capital, Temasek Holdings, Verily Life Sciences, Third Rock Ventures, Globalive Capital, WuXi AppTec, ADS Ventures, CPP Investments, Casdin Capital, ARCH Venture Partners.